YZJ-1139

DRUG5 trials

Sponsors

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.

Conditions

Hepatic ImpairmentInsomniaInsomnia DisorderRenal Impairment

Phase 1

Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Severe Renal Impairment and Normal Renal Impairment

CompletedNCT06671444

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.Insomnia, Renal Impairment

Start: 2024-06-03End: 2024-11-06Updated: 2026-06-30

Pharmacokinetics and Safety Study of YZJ-1139 in Subjects With Mild, Moderate and Normal Hepatic Impairment

CompletedNCT06671509

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.Hepatic Impairment, Insomnia

Start: 2024-03-22End: 2024-08-07Updated: 2024-11-04

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of YZJ-1139 in Healthy Participants

CompletedNCT06673927

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.Insomnia

Start: 2017-12-01End: 2019-03-08Updated: 2025-02-10

PK/PD Study of YZJ-1139

CompletedNCT06685341

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.Insomnia

Start: 2019-03-07End: 2019-11-15Updated: 2024-11-12

Phase 3

Safety and Efficacy Study of YZJ-1139 Tablets in Insomnia Disorder

CompletedNCT06975514

Shanghai Haiyan Pharmaceutical Technology Co., Ltd.Insomnia Disorder

Start: 2025-03-25End: 2025-08-14Updated: 2026-06-29